- Today
- Holidays
- Birthdays
- Reminders
- Cities
- Atlanta
- Austin
- Baltimore
- Berwyn
- Beverly Hills
- Birmingham
- Boston
- Brooklyn
- Buffalo
- Charlotte
- Chicago
- Cincinnati
- Cleveland
- Columbus
- Dallas
- Denver
- Detroit
- Fort Worth
- Houston
- Indianapolis
- Knoxville
- Las Vegas
- Los Angeles
- Louisville
- Madison
- Memphis
- Miami
- Milwaukee
- Minneapolis
- Nashville
- New Orleans
- New York
- Omaha
- Orlando
- Philadelphia
- Phoenix
- Pittsburgh
- Portland
- Raleigh
- Richmond
- Rutherford
- Sacramento
- Salt Lake City
- San Antonio
- San Diego
- San Francisco
- San Jose
- Seattle
- Tampa
- Tucson
- Washington
Warsaw Today
By the People, for the People
SNDL vs. Zimmer Biomet: A Financial Comparison
Two medical companies face off in a financial analysis
Apr. 10, 2026 at 9:10am
Got story updates? Submit your updates here. ›
An extreme close-up of the inner workings of the financial industry, highlighting the complex machinery that underpins modern banking and investment.Warsaw TodaySNDL (NASDAQ:SNDL) and Zimmer Biomet (NYSE:ZBH) are both medical companies, but which one is the superior business? This article compares the two based on factors like dividends, earnings, profitability, valuation, risk, analyst recommendations, and institutional ownership.
Why it matters
This analysis provides valuable insights for investors looking to compare and contrast these two medical industry players. Understanding the financial strengths and weaknesses of SNDL and Zimmer Biomet can help inform investment decisions in the healthcare sector.
The details
The article breaks down key financial metrics for the two companies, including gross revenue, earnings per share, net margins, return on equity, and return on assets. It also examines factors like institutional ownership, analyst recommendations, and stock price volatility. Overall, the data suggests Zimmer Biomet has the edge over SNDL across most of these measures.
- The financial data and analysis is current as of April 10, 2026.
The players
SNDL Inc.
A Canadian company that engages in the production, distribution, and sale of cannabis products for the adult-use and medical markets.
Zimmer Biomet Holdings, Inc.
A global medical technology company that designs, manufactures, and markets orthopedic reconstructive products, surgical products, and other medical solutions.
The takeaway
This comparison highlights the financial strengths of Zimmer Biomet over SNDL, with the former outperforming the latter across key metrics like profitability, institutional ownership, and stock price volatility. Investors looking to gain exposure to the medical technology sector may find Zimmer Biomet to be the more attractive investment option based on this analysis.
